Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats
about
Pharmacokinetics of mangiferin and its metabolite-Norathyriol, Part 1: Systemic evaluation of hepatic first-pass effect in vitro and in vivo.Pharmacokinetics of mangiferin and its metabolite-norathyriol, Part 2: Influence of UGT, CYP450, P-gp, and enterobacteria and the potential interaction in Rhizoma Anemarrhenae decoction with timosaponin B2 as the major contributor.Elucidation of stress-induced degradation products of mangiferin: Method development and validation.Enterogenous bacterial glycolipids are required for the generation of natural killer T cells mediated liver injuryExploring and validating physicochemical properties of mangiferin through GastroPlus® software.Mangiferin: A xanthonoid with multipotent anti-inflammatory potential.Mangiferin: A review of sources and interventions for biological activities.Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment.The gut microbiota and obesity: from correlation to causality.Metabolic profile and underlying improved bio-activity of Fructus aurantii immaturus by human intestinal bacteria.Simultaneous determination of multiple active components in rat plasma using ultra-fast liquid chromatography with tandem mass spectrometry and application to a comparative pharmacokinetic study after oral administration of Suan-Zao-Ren decoction anIsomangiferin, a Novel Potent Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor, Suppresses Breast Cancer Growth, Metastasis and Angiogenesis.
P2860
Q36003898-9729F957-C098-4096-958C-83F7AB85AEDFQ36010300-320F28CB-9663-4F21-A973-D77ED84EE1AAQ36250330-029B8950-D58E-4406-97E7-0107BD362D90Q37399621-137C44D1-55C0-4A21-979E-EC6AA8A76387Q38739454-42A5FC1F-D346-48CB-AD8D-913278C888C6Q38807645-277C9A30-3DD0-4C23-8139-91CDE3605AC5Q38961736-43CF5363-D637-47A5-ADA0-294AAD31E1CEQ39111404-39E4952E-D0B9-41D9-8D31-06155B9ECA31Q44559588-24E30757-0E56-44E6-B390-90BABCACDA4CQ46365916-388C1F17-C37D-436D-B8F4-BAFF12BA1053Q47750221-7EFED62E-E3BD-49A6-B505-97696332C86CQ52599657-350B8589-D4DD-477C-851F-C9FD1FE7450D
P2860
Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats
description
im November 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2012
@uk
name
Metabolism and pharmacokinetic ...... ozotocin-induced diabetic rats
@en
Metabolism and pharmacokinetic ...... ozotocin-induced diabetic rats
@nl
type
label
Metabolism and pharmacokinetic ...... ozotocin-induced diabetic rats
@en
Metabolism and pharmacokinetic ...... ozotocin-induced diabetic rats
@nl
prefLabel
Metabolism and pharmacokinetic ...... ozotocin-induced diabetic rats
@en
Metabolism and pharmacokinetic ...... ozotocin-induced diabetic rats
@nl
P2093
P356
P1476
Metabolism and pharmacokinetic ...... ozotocin-induced diabetic rats
@en
P2093
Chenggang Huang
Huihui Liu
Longhai Jian
Mingcang Chen
Mingsong Fan
Zhixiong Li
P304
P356
10.1124/DMD.112.045849
P407
P577
2012-11-01T00:00:00Z